从生物质到电力:高性能反应堆设计,用于耐焦化作业
Bin Wang1, Tong Wang1, Dongxu Cui2
1MOE Key Laboratory of Energy Thermal Conversion & Control, School of Energy and Environment, Southeast University, Nanjing 210096, China.
Bioresource technology
|November 8, 2024
概括
本研究提出了一种新的固体氧化物燃料电池 (SOFC) 设计,用于从生物质气化中高效发电. 创新的结构提高了高惰性气体含量的性能,并确保了稳定的运行,为清洁能源解决方案铺平了道路.
科学领域:
- 能源转化和储存 能源转化和储存
- 材料科学 材料科学 材料科学
- 环境工程 环境工程
背景情况:
- 生物质气化与固体氧化物燃料电池 (SOFC) 技术相结合,为清洁能源发电提供了一个碳中和的途径.
- 生物质衍生合成气通常含有高度的惰性气体,这对SOFC的性能和耐用性构成了挑战.
- 现有的SOFC技术需要进一步优化,以有效地利用复杂的合成气组成.
研究的目的:
- 开发一种具有独特结构设计的高性能SOFC,能够利用具有高惰性含量的生物质气化合成气.
- 通过结构工程来研究减轻惰性气体稀释对SOFC性能的影响.
- 评估开发的SOFC系统在由生物质气化合成气为燃料时的运行稳定性和耐用性.
主要方法:
- 开发基于NiO-yttria稳定 (YSZ) 的多通道,层次结构设计的SOFC.
- 在SOFC架构中集成增强的接口电化学反应.
- 使用生物质气化合成气测试SOFC的性能和稳定性,其中约60%的惰性成分在750°C.
- 通过对支持区域和活性区域的空间分离来评估碳沉积控制.
主要成果:
- 开发的SOFC在750°C下使用含有近60%惰性元件的合成气时,达到2.07W·cm−2的功率密度.
- 独特的结构设计和增强的电化学反应有效地减轻了因惰性气体稀释引起的性能退化.
- SOFC以干燥生物质气化合成气进行了100小时的稳定运行,这归因于受控的碳沉积.
- 惰性支和电化学活性区域的空间分离在管理碳沉积物方面被证明是有效的.
结论:
- 新的多通道,层次结构设计在利用具有挑战性的生物质气化合成气时显著提高了SOFC的性能.
- 这种方法有效地解决了高惰性气体度和生物质燃料SOFC中碳沉积所带来的局限性.
- 稳定,长期运行的成功演示凸显了这种微管 SOFC 技术在生物质废物可持续能源生产方面的有前途潜力.
相关概念视频
Nuclear Power
7.5K
Controlled nuclear fission reactions are used to generate electricity. Any nuclear reactor that produces power via the fission of uranium or plutonium by bombardment with neutrons has six components: nuclear fuel consisting of fissionable material, a nuclear moderator, a neutron source, control rods, reactor coolant, and a shield and containment system.
Nuclear Fuels
Nuclear fuel consists of a fissile isotope, such as uranium-235, which must be present in sufficient quantity to provide a...
Nuclear Fuels
Nuclear fuel consists of a fissile isotope, such as uranium-235, which must be present in sufficient quantity to provide a...
7.5K
Bioreactor Design and Operational System
200
Bioreactors are engineered vessels designed to cultivate microorganisms under controlled conditions for industrial bioprocessing. They maintain sterility and allow precise regulation of pH, temperature, oxygen, and nutrient levels to optimize microbial growth and metabolite production. Bioreactors range from small laboratory units of 1 liter to industrial systems holding up to 500,000 liters, though only about 75% of their volume is actively used for fermentation. The remaining headspace...
200
Bioreactor Controls-II
76
In aerobic fermentations, oxygen is vital for microbial growth and metabolite production. Since air comprises only about 20% oxygen and the gas is poorly soluble in water—just 9 ppm at 20°C—supplying sufficient oxygen becomes a critical challenge, especially in high-demand processes like yeast growth or citric acid production. Even a fully saturated broth may offer only a few seconds of oxygen availability.To address this, sterile or scrubbed air is introduced into the...
76
Bioreactor Controls-III
67
Strain improvement is a foundational strategy in industrial microbiology aimed at maximizing microbial productivity, particularly because natural isolates typically yield commercially valuable products in very low concentrations. Although optimizing the culture medium and environmental conditions can improve yields, these adjustments are inherently limited by the organism’s genetic potential. As a result, the focus shifts toward genetic modifications to enhance biosynthetic capacity. The...
67
Designing Growth Media for Bioreactors
78
Growth media provide essential nutrients that support cell growth and metabolism, thereby enhancing the yield of valuable products such as enzymes, antibiotics, and biomass. Designing an effective growth medium involves balancing all components to prevent nutrient limitations or toxic excesses, both of which can impair growth and reduce product yields.Composition of a Typical Growth MediumA typical growth medium contains carbon and nitrogen sources, salts, vitamins, trace elements, and...
78
Upstream Processing
97
Upstream processing represents a critical phase in biomanufacturing, wherein biological systems such as microorganisms, mammalian cells, or insect cells are cultivated to produce therapeutic proteins, vaccines, enzymes, or other biologically derived products. This phase encompasses all steps from the selection and genetic manipulation of the production organism to the cultivation of cells in bioreactors under tightly controlled environmental conditions.Host Selection and Genetic OptimizationThe...
97


